SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Tomorrow.io raises $175 million at over $1 billion valuation to build AI-driven weather satellite network

Cyber startup Orion raises $32 million Series A backed by IBM for AI-driven data-leak prevention

Full list of Israeli startup M&As in 2026

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

Buzz

Most popular

Daily

Weekly

1

Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”

2

Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race

3

After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights

4

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

5

Why Apple paid billions for a company with no revenue

PhaseV

4 stories about PhaseV

Promising HealthTech

WATCH: CTech's most promising healthtech startups

Here's everything you need to know about Sensi.ai, Briya Labs, PhaseV, Zorro, and DeepCure

כנס ניו יורק - ד"ר רביב פרילוק מנכ"ל PhaseV

PhaseV raises $50 million Series A to rethink how drugs get to market

With over 30 global customers, the AI startup targets inefficiencies in clinical trials.

CTech NY Conference Dr Raviv Pryluk

Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development

27.03.25|James Spiro

CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York.

Raviv Pryluk PhaseV

PhaseV raises $15 million to optimize clinical trials with causal machine learning

The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps